GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q1 2024
Top Holdings45 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TENET HEALTHCARE CORP | 6.3M | $665.1M | 11.6% | $35.04 | +199.95% | 22 qtrssince 2018-Q4 | Decreased 0 |
THE CIGNA GROUP | 1.5M | $534.5M | 9.3% | $231.33 | +50.28% | 22 qtrssince 2018-Q4 | Decreased 0 |
CORTEVA INC | 6.8M | $391.4M | 6.8% | $50.77 | +11.47% | 18 qtrssince 2019-Q4 | Increased 83 |
UNIVERSAL HEALTH SERVICES-B | 2.1M | $374.9M | 6.6% | $147.97 | +22.45% | 6 qtrssince 2022-Q4 | Increased 73 |
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 660,000 | $345.2M | 6.0% | — | — | — | New — |
GLOBAL PAYMENTS INC | 2.4M | $319.2M | 5.6% | $145.96 | -10.14% | 14 qtrssince 2020-Q4 | Increased 74 |
ALIGHT INC | 28.3M | $279M | 4.9% | $8.54 | +10.22% | 7 qtrssince 2022-Q3 | Increased 81 |
DXC TECHNOLOGY CO | 12.8M | $271.1M | 4.7% | $34.05 | -37.71% | 22 qtrssince 2018-Q4 | Decreased 0 |
ISHARES RUSSELL 2000 ETF ETF | 1.2M | $243M | 4.2% | — | — | — | Decreased — |
ELEMENT SOLUTIONS INC | 8.4M | $208.8M | 3.7% | $21.17 | +15.39% | 21 qtrssince 2019-Q1 | Increased 92 |
CLARIVATE PLC | 24.7M | $183.2M | 3.2% | $9.26 | -19.77% | 8 qtrssince 2022-Q2 | Increased 57 |
MCKESSON CORP | 287,961 | $154.6M | 2.7% | $144.46 | +268.77% | 22 qtrssince 2018-Q4 | Decreased 0 |
US FOODS HOLDING CORP | 2.5M | $136.2M | 2.4% | $41.89 | +28.82% | 10 qtrssince 2021-Q4 | Increased 71 |
CVS HEALTH CORPORATION | 1.7M | $135.3M | 2.4% | $71.79 | +0.84% | 2 qtrssince 2023-Q4 | Increased 85 |
FISERV INC | 802,692 | $128.3M | 2.2% | $106.06 | +50.68% | 19 qtrssince 2019-Q3 | Decreased 0 |
TEVA PHARMACEUTICAL-SP ADR | 7.5M | $105.8M | 1.9% | $13.32 | +5.89% | 2 qtrssince 2023-Q4 | Increased 77 |
MYRIAD GENETICS INC | 4.9M | $105.4M | 1.8% | $18.94 | +12.55% | 19 qtrssince 2019-Q3 | Decreased 0 |
MARVELL TECHNOLOGY INC | 1.4M | $97.1M | 1.7% | $69.05 | +2.01% | 2 qtrssince 2023-Q4 | Increased 77 |
BROOKDALE SR LIVING INC | 14.4M | $95.5M | 1.7% | $4.69 | +40.83% | 22 qtrssince 2018-Q4 | Decreased 0 |
ANTHEM INC | 174,229 | $90.3M | 1.6% | $490.22 | +2.72% | 3 qtrssince 2023-Q3 | Increased 77 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $5.7B across 45 positions as of Q1 2024. Top holdings: THC (11.6%), CI (9.3%), CTVA (6.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 6 new positions, 4 exits, 15 increased. Top move: ESI (INCREASED, conviction 92). Portfolio: $5.7B across 45 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer